Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.31 Insider Own70.44% Shs Outstand29.65M Perf Week147.46%
Market Cap23.38M Forward P/E- EPS next Y-1.12 Insider Trans0.00% Shs Float8.86M Perf Month98.94%
Income-38.89M PEG- EPS next Q-0.27 Inst Own5.51% Short Float1.80% Perf Quarter159.91%
Sales30.00M P/S0.78 EPS this Y22.42% Inst Trans-12.78% Short Ratio0.31 Perf Half Y-43.07%
Book/sh0.59 P/B1.32 EPS next Y12.50% ROA-39.52% Short Interest0.16M Perf Year-54.65%
Cash/sh1.39 P/C0.56 EPS next 5Y- ROE-76.49% 52W Range0.30 - 3.32 Perf YTD95.49%
Dividend Est.- P/FCF- EPS past 5Y- ROI-48.95% 52W High-76.51% Beta1.81
Dividend TTM- Quick Ratio1.91 Sales past 5Y84.41% Gross Margin53.87% 52W Low160.00% ATR (14)0.07
Dividend Ex-Date- Current Ratio2.07 EPS Y/Y TTM27.25% Oper. Margin-123.14% RSI (14)87.53 Volatility32.74% 14.23%
Employees243 Debt/Eq1.07 Sales Y/Y TTM42.56% Profit Margin-129.63% Recom1.67 Target Price4.00
Option/ShortYes / No LT Debt/Eq0.71 EPS Q/Q10.35% Payout- Rel Volume41.03 Prev Close0.46
Sales Surprise-24.81% EPS Surprise-24.71% Sales Q/Q-16.64% EarningsNov 13 AMC Avg Volume519.07K Price0.78
SMA20133.16% SMA50119.81% SMA200-25.22% Trades Volume21,296,261 Change70.27%
Today 08:44AM
Nov-13-23 05:32PM
Nov-07-23 09:00AM
Nov-03-23 12:00PM
03:48PM Loading…
Sep-28-23 03:48PM
Aug-29-23 04:05PM
Aug-10-23 04:51PM
Aug-03-23 05:00PM
Jun-08-23 09:05AM
Jun-06-23 03:00AM
Jun-05-23 05:30PM
May-31-23 05:29PM
May-23-23 09:00AM
12:00PM Loading…
May-22-23 12:00PM
May-18-23 10:00AM
May-15-23 09:00AM
May-13-23 08:05AM
May-12-23 04:17PM
May-11-23 05:25PM
Apr-27-23 04:05PM
Apr-17-23 07:50AM
Mar-31-23 09:00AM
Mar-28-23 04:59AM
Mar-25-23 08:21AM
Mar-21-23 05:25PM
04:05PM Loading…
Mar-16-23 06:00AM
Mar-14-23 06:00AM
Mar-09-23 04:30PM
Feb-27-23 09:00AM
Feb-16-23 09:00AM
Jan-09-23 09:00AM
Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nelson Todd RobertPresident & CEOMay 04Sale2.832,5757,277136,072May 08 08:11 PM
Gibson Daniel GlennChief Technology OfficerMay 04Sale2.831,1903,363102,083May 08 08:09 PM
Cutler RobChief Legal OfficerMay 04Sale2.831,1743,31825,468May 08 08:06 PM